Sanaz Ahmadi Ghezeldasht
Overview
Explore the profile of Sanaz Ahmadi Ghezeldasht including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ahmadi Ghezeldasht S, Mosavat A, Rezaee S
Rev Med Virol
. 2024 Jun;
34(4):e2567.
PMID: 38937135
Human T-lymphotropic virus type-1 (HTLV-1) was the first discovered human oncogenic retrovirus, the etiological agent of two serious diseases have been identified as adult T-cell leukaemia/lymphoma malignancy and HTLV-1-associated myelopathy/tropical...
2.
Hedayati-Moghaddam M, Tehranian F, Mosavat A, Miri R, Ahmadi Ghezeldasht S
Arch Iran Med
. 2024 Jun;
27(6):305-312.
PMID: 38855800
Background: Occult hepatitis B infection (OBI) refers to the presence of hepatitis B virus (HBV) DNA in the serum or liver of individuals who tested negative for HBV surface antigen...
3.
Fadaee A, Mohammadi F, Ariaee N, Ahmadi Ghezeldasht S, Valizadeh N, Kheradmand F, et al.
Mult Scler Relat Disord
. 2024 May;
87:105659.
PMID: 38704874
Background/aim: The roles of endocannabinoids are described in immune modulation and neuroprotection. HTLV-1-associated myelopathy (HAM/TSP) is an inflammatory neurodegenerative disease. Therefore, in this study, the interactions of HTLV-1 regulatory factors...
4.
Ariaee N, Abbasnia S, Sabet F, Mirhossein A, Ahmadi Ghezeldasht S, Moshfegh M, et al.
Rep Biochem Mol Biol
. 2024 Apr;
12(3):393-402.
PMID: 38618262
Background: The significance of HTLV-1 proviral load as a prognostic biomarker in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) has been a subject of controversy. This study aims to assess the impact...
5.
Ahmadi Ghezeldasht S, Bidkhori H, Miri R, Baghban A, Mosavat A, Rezaee S
J Neurovirol
. 2023 Aug;
PMID: 37531001
There is an urgent need to find an effective therapy for life-threatening HTLV-1-associated diseases. Bitter melon (Momordica charantia) is considered a traditional herb with antiviral and anticancer properties and was...
6.
Ahmadi Ghezeldasht S, Soleimanpour S, Hedayati-Moghaddam M, Farshchian M, Rezaee S, Mosavat A
J Virus Erad
. 2023 Jul;
9(2):100333.
PMID: 37408699
One third of the world population has a history of exposure to the hepatitis B virus (HBV), and two billion people are infected with latent tuberculosis (TB). Occult hepatitis B...
7.
Role of host immunity and HBx among inactive chronic hepatitis B patients in a highly endemic region
Yousefpoor N, Mahdavian M, Pourbagher Z, Ahmadi Ghezeldasht S, Mosavat A, Ziaee M, et al.
Microb Pathog
. 2023 May;
181:106170.
PMID: 37257667
The hepatitis B virus (HBV) infection has a wide range, from fulminant hepatitis to inactive chronic hepatitis B (ICB) infection. The present study evaluated critical factors in the outcomes of...
8.
Ahmadi Ghezeldasht S, Blackbourn D, Mosavat A, Rezaee S
Crit Rev Clin Lab Sci
. 2023 Jan;
60(3):189-211.
PMID: 36593730
Adult T-cell leukemia/lymphoma (ATLL) is an aggressive malignancy of CD4 T lymphocytes caused by human T lymphotropic virus type-1 (HTLV-1) infection. HTLV-1 was brought to the World Health Organization (WHO)...
9.
Ahmadi Ghezeldasht S, Momen Heravi M, Valizadeh N, Rafatpanah H, Shamsian S, Mosavat A, et al.
Appl Biochem Biotechnol
. 2022 Nov;
195(3):1862-1876.
PMID: 36399306
Human T-cell leukaemia virus type 1 (HTLV-1) is the causative agent of two life-threatening diseases, adult T cell leukaemia/lymphoma (ATLL), and HTLV-1-associated myelopathy/tropical spastic (HAM/TSP). HTLV-1 protease (HTLV-1-PR) is an...
10.
Ashrafi F, Rahimzada M, Parandi M, Mirhosseini A, Mashkani B, Ahmadi Ghezeldasht S, et al.
Gene
. 2022 Sep;
847:146885.
PMID: 36108787
The outcome of successful infection, including human T-cell leukemia virus type 1 (HTLV-1), is determined by the interactions between the host and the infectious agent. Ten years of work on...